Skip to main content
Signal8
Sandler Andrew Seth profile photo

Andrew Seth Sandler

CIK: 0001596060

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Dermata Therapeutics, Inc. logo
DRMA

Dermata Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Dermata Therapeutics, Inc. logo
    DRMA

    Dermata Therapeutics, Inc.

    Jan 2, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    2.5K shares-
  • Dermata Therapeutics, Inc. logo
    DRMA

    Dermata Therapeutics, Inc.

    Jan 13, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    5K shares-

1-2 of 2

About Sandler Andrew Seth

Sandler Andrew Seth (SEC CIK 0001596060) files insider reports with the SEC as Director of Dermata Therapeutics, Inc. (DRMA).

Signal8 holds 2 ownership filings by Sandler Andrew Seth, all Form 4s, filed between Jan 14, 2025 and Jan 6, 2026. Those filings report 2 transactions, from Jan 13, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sandler Andrew Seth's filings is in SAN DIEGO, CA.

Recent filings by Sandler Andrew Seth

  • Jan 2, 2026: Grant or award of DRMA derivative securities (Form 4, code A).
  • Jan 13, 2025: Grant or award of DRMA derivative securities (Form 4, code A).

Other insiders filing for Dermata Therapeutics, Inc. (DRMA)

How to read Form 4 transaction codes